Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- USD | -.--% | -6.22% | +78.50% |
2018 | Transcript : Argos Therapeutics, Inc. - Special Call | |
2017 | Transcript : Argos Therapeutics, Inc., Q3 2017 Earnings Call, Nov 13, 2017 |
Kurzporträt
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 10 586 661 | 9 393 074 ( 88,73 %) | 0 | 88,73 % |
Unternehmenskontakt
Argos Therapeutics, Inc.
4233 Technology Drive
27704-2173, Durham
+919-287-6300
http://www.argostherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+78.50% | 566’915 | |
+2.99% | 95.18 Mrd. | |
-4.34% | 37.55 Mrd. | |
-10.41% | 33.75 Mrd. | |
+75.79% | 28.2 Mrd. | |
-14.61% | 15.63 Mrd. | |
-3.46% | 13.63 Mrd. | |
-12.31% | 11.5 Mrd. | |
+184.77% | 10.81 Mrd. | |
-54.13% | 9.23 Mrd. |
- Börse
- Aktien
- A2G8YQ Aktie
- Unternehmen Argos Therapeutics, Inc.